[PHARMA] YoY TTM Result on 30-Sep-2013 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- -44.83%
YoY- -67.58%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 2,286,356 2,136,265 2,063,690 1,861,183 1,697,728 1,529,311 1,326,138 9.49%
PBT 91,665 126,859 120,733 64,238 115,434 54,117 75,653 3.24%
Tax -28,865 -21,695 -41,862 -36,212 -32,578 -15,466 -21,273 5.21%
NP 62,800 105,164 78,871 28,026 82,856 38,651 54,380 2.42%
-
NP to SH 62,497 104,679 77,960 26,453 81,587 37,959 54,554 2.28%
-
Tax Rate 31.49% 17.10% 34.67% 56.37% 28.22% 28.58% 28.12% -
Total Cost 2,223,556 2,031,101 1,984,819 1,833,157 1,614,872 1,490,660 1,271,758 9.74%
-
Net Worth 531,250 534,373 507,124 473,402 496,469 464,092 424,488 3.80%
Dividend
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Div 51,803 90,625 57,457 37,168 64,713 - 89,852 -8.76%
Div Payout % 82.89% 86.57% 73.70% 140.51% 79.32% - 164.70% -
Equity
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Net Worth 531,250 534,373 507,124 473,402 496,469 464,092 424,488 3.80%
NOSH 259,146 259,027 258,737 258,689 117,646 106,933 106,924 15.88%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin 2.75% 4.92% 3.82% 1.51% 4.88% 2.53% 4.10% -
ROE 11.76% 19.59% 15.37% 5.59% 16.43% 8.18% 12.85% -
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 882.26 824.73 797.60 719.47 1,443.07 1,430.15 1,240.26 -5.51%
EPS 24.12 40.41 30.13 10.23 69.35 35.50 51.02 -11.72%
DPS 20.00 35.00 22.20 14.37 55.00 0.00 84.00 -21.25%
NAPS 2.05 2.063 1.96 1.83 4.22 4.34 3.97 -10.42%
Adjusted Per Share Value based on latest NOSH - 258,689
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
RPS 158.64 148.23 143.19 129.14 117.80 106.11 92.01 9.49%
EPS 4.34 7.26 5.41 1.84 5.66 2.63 3.79 2.28%
DPS 3.59 6.29 3.99 2.58 4.49 0.00 6.23 -8.77%
NAPS 0.3686 0.3708 0.3519 0.3285 0.3445 0.322 0.2945 3.80%
Price Multiplier on Financial Quarter End Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 -
Price 5.58 6.50 4.63 4.82 7.55 5.90 4.98 -
P/RPS 0.63 0.79 0.58 0.67 0.52 0.41 0.40 7.85%
P/EPS 23.14 16.08 15.37 47.14 10.89 16.62 9.76 15.45%
EY 4.32 6.22 6.51 2.12 9.19 6.02 10.25 -13.40%
DY 3.58 5.38 4.79 2.98 7.28 0.00 16.87 -22.75%
P/NAPS 2.72 3.15 2.36 2.63 1.79 1.36 1.25 13.82%
Price Multiplier on Announcement Date
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Date 21/11/16 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 04/11/10 -
Price 5.70 6.50 4.45 4.72 8.25 5.90 4.92 -
P/RPS 0.65 0.79 0.56 0.66 0.57 0.41 0.40 8.42%
P/EPS 23.64 16.08 14.77 46.16 11.90 16.62 9.64 16.10%
EY 4.23 6.22 6.77 2.17 8.41 6.02 10.37 -13.87%
DY 3.51 5.38 4.99 3.04 6.67 0.00 17.07 -23.15%
P/NAPS 2.78 3.15 2.27 2.58 1.95 1.36 1.24 14.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment